What is Zoned Pptys Inc's earnings per share (EPS)?

Zoned Pptys Inc (ZDPY) reported diluted earnings per share of $-0.24 for fiscal year 2025. This represents a -500.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Zoned Pptys Inc Financials

ZDPY

Source SEC Filings (10-K/10-Q) Updated Apr 1, 2026 Currency USD FYE April

This page shows Zoned Pptys Inc (ZDPY) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 14 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Earnings Quality Mixed

-0.27x

For every $1 of reported earnings, Zoned Pptys Inc generates $-0.27 in operating cash flow ($781K OCF vs -$2.9M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Interest Coverage At Risk

-2.8x

Zoned Pptys Inc earns $-2.8 in operating income for every $1 of interest expense (-$1.9M vs $677K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$3.1M

YoY-18.8%

5Y CAGR+20.4%

10Y CAGR+8.1%

Zoned Pptys Inc generated $3.1M in revenue in fiscal year 2025. This represents a decrease of 18.8% from the prior year.

EBITDA

-$1.5M

YoY-204.3%

Zoned Pptys Inc's EBITDA was -$1.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 204.3% from the prior year.

Net Income

-$2.9M

YoY-597.3%

Zoned Pptys Inc reported -$2.9M in net income in fiscal year 2025. This represents a decrease of 597.3% from the prior year.

EPS (Diluted)

$-0.24

YoY-500.0%

Zoned Pptys Inc earned $-0.24 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 500.0% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$775K

YoY+35.6%

5Y CAGR+35.6%

Zoned Pptys Inc generated $775K in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 35.6% from the prior year.

Cash & Debt

N/A

Dividends Per Share

N/A

Shares Outstanding

13M

YoY+9.0%

5Y CAGR+1.9%

10Y CAGR-2.6%

Zoned Pptys Inc had 13M shares outstanding in fiscal year 2025. This represents an increase of 9.0% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

-61.2%

YoY-90.3pp

5Y CAGR-64.3pp

10Y CAGR+19.5pp

Zoned Pptys Inc's operating margin was -61.2% in fiscal year 2025, reflecting core business profitability. This is down 90.3 percentage points from the prior year.

Net Margin

-92.7%

YoY-107.8pp

5Y CAGR-86.2pp

10Y CAGR+4.0pp

Zoned Pptys Inc's net profit margin was -92.7% in fiscal year 2025, showing the share of revenue converted to profit. This is down 107.8 percentage points from the prior year.

Return on Equity

N/A

Capital Allocation

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

$6K

YoY+0.0%

5Y CAGR+47.7%

10Y CAGR-0.7%

Zoned Pptys Inc invested $6K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 0.0% from the prior year.

ZDPY Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$3.1M-18.8%	$3.8M+31.4%	$2.9M+8.5%	$2.7M+46.1%	$1.8M+49.8%	$1.2M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$308K-7.0%	$331K-9.7%	$367K+33.1%	$276K+36.8%	$202K+5.7%	$191K
Operating Income	-$1.9M-270.9%	$1.1M+552.0%	$169K+255.3%	-$109K-343.7%	$45K+18.5%	$38K
Interest Expense	-$677K-197.2%	$697K+11.5%	$625K+287.6%	$161K+1228.9%	$12K	N/A
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	-$2.9M-597.3%	$574K+206.2%	-$540K+5.9%	-$574K-246.4%	-$166K-111.7%	-$78K
EPS (Diluted)	$-0.24-500.0%	$0.06+250.0%	$-0.04+20.0%	$-0.05-400.0%	$-0.010.0%	$-0.01

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Revenue	$1.0M+8.0%	$938K-3.8%	$975K-21.0%	$1.2M+19.9%	$1.0M+48.7%	$692K-17.3%	$837K+18.6%	$706K
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$63K-3.3%	$65K+16.1%	$56K-18.5%	$69K-19.0%	$85K-15.0%	$100K+26.4%	$79K-15.2%	$93K
Operating Income	$367K+35.0%	$272K-36.5%	$429K+0.7%	$426K-4.3%	$445K+331.6%	$103K-20.0%	$129K+63.9%	$79K
Interest Expense	$198K+0.4%	$197K+1.2%	$195K-0.2%	$195K+4.1%	$187K+19.7%	$156K-1.0%	$158K+0.1%	$158K
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	$155K+489.5%	$26K-82.0%	$146K-67.7%	$451K+665.9%	$59K+282.4%	-$32K-133.5%	$96K+124.9%	-$387K
EPS (Diluted)	$0.02	$0.00-100.0%	$0.01	N/A	$0.00	$0.00-100.0%	$0.01	N/A

ZDPY Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	N/A	$16.2M+12.1%	$14.4M+0.4%	$14.4M+76.7%	$8.1M+0.1%	$8.1M
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	N/A	$1.0M-67.1%	$3.1M-28.5%	$4.3M+263.8%	$1.2M+70.4%	$699K
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	$370K+171.0%	$137K-1.6%	$139K+1655.3%	$8K+58.6%	$5K
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	N/A	$10.3M+12.2%	$9.2M+5.7%	$8.7M+291.7%	$2.2M+1.3%	$2.2M
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	N/A	$7.2M	N/A	N/A	N/A	N/A
Total Equity	N/A	$5.9M+11.8%	$5.2M-7.7%	$5.7M-4.0%	$5.9M-0.3%	$5.9M
Retained Earnings	N/A	-$15.6M+3.5%	-$16.2M-3.4%	-$15.7M-3.8%	-$15.1M-1.1%	-$14.9M

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Total Assets	$16.8M+0.8%	$16.7M+0.4%	$16.6M+2.7%	$16.2M+3.1%	$15.7M+8.1%	$14.5M-0.8%	$14.6M+1.4%	$14.4M
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$1.1M+13.0%	$986K-0.8%	$994K-2.6%	$1.0M-11.5%	$1.2M-24.6%	$1.5M+0.6%	$1.5M-51.0%	$3.1M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$300K+37.8%	$217K-12.4%	$248K-33.0%	$370K+251.6%	$105K+33.6%	$79K-56.1%	$179K+31.4%	$137K
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$10.6M-0.4%	$10.6M+0.5%	$10.6M+2.2%	$10.3M+0.2%	$10.3M+12.1%	$9.2M-1.1%	$9.3M+1.0%	$9.2M
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	$7.4M-0.3%	$7.5M-0.3%	$7.5M+4.1%	$7.2M-0.6%	$7.2M+16.0%	$6.2M	N/A	N/A
Total Equity	$6.2M+2.8%	$6.1M+0.2%	$6.1M+3.5%	$5.9M+8.5%	$5.4M+1.2%	$5.3M-0.4%	$5.4M+2.2%	$5.2M
Retained Earnings	-$15.3M+1.0%	-$15.5M+0.2%	-$15.5M+0.9%	-$15.6M+2.8%	-$16.1M+0.4%	-$16.1M-0.2%	-$16.1M+0.6%	-$16.2M

ZDPY Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$781K+35.2%	$578K+600.5%	$83K-90.5%	$872K+78.2%	$489K+187.7%	$170K
Capital Expenditures	$6K0.0%	$6K+500.6%	$1K-71.3%	$4K+43.4%	$3K+184.3%	$923
Free Cash Flow	$775K+35.6%	$572K+601.8%	$81K-90.6%	$868K+78.4%	$487K+187.7%	$169K
Investing Cash Flow	-$1.4M+59.2%	-$3.5M-184.7%	-$1.2M+38.3%	-$2.0M-60112.3%	$3K+103.0%	-$110K
Financing Cash Flow	$476K-45.3%	$870K+1194.1%	-$80K-101.9%	$4.3M	N/A	N/A
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Operating Cash Flow	$92K-61.7%	$239K-27.7%	$331K+169.1%	$123K-41.1%	$209K+532.6%	$33K-84.6%	$214K+294.3%	$54K
Capital Expenditures	N/A	N/A	N/A	$0	$0	$0-100.0%	$6K	N/A
Free Cash Flow	N/A	N/A	N/A	$123K-41.1%	$209K+532.6%	$33K-84.1%	$207K	N/A
Investing Cash Flow	$61K+130.7%	-$197K+69.7%	-$649K-210.4%	-$209K+86.5%	-$1.5M-90639.7%	-$2K+99.9%	-$1.8M-3143.4%	$58K
Financing Cash Flow	-$24K+52.3%	-$50K-117.3%	$292K+735.8%	-$46K-104.8%	$960K+4345.7%	-$23K-3.8%	-$22K-10.6%	-$20K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

ZDPY Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	-61.2%-90.3pp	29.1%+23.2pp	5.9%+10.0pp	-4.1%-6.6pp	2.5%-0.6pp	3.1%
Net Margin	-92.7%-107.8pp	15.1%+33.8pp	-18.7%+2.9pp	-21.6%-12.5pp	-9.1%-2.7pp	-6.5%
Return on Equity	N/A	9.8%+20.1pp	-10.3%-0.2pp	-10.1%-7.3pp	-2.8%-1.5pp	-1.3%
Return on Assets	N/A	3.5%+7.3pp	-3.7%+0.2pp	-4.0%-1.9pp	-2.0%-1.1pp	-1.0%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	N/A	1.23-0.5	1.76+0.2	1.53+1.2	0.380.0	0.37
FCF Margin	25.2%+10.1pp	15.1%+12.3pp	2.8%-29.8pp	32.6%+5.9pp	26.7%+12.8pp	13.9%

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	36.3%+7.2pp	29.0%-15.0pp	44.0%+9.5pp	34.5%-8.7pp	43.2%+28.3pp	14.9%-0.5pp	15.4%+4.3pp	11.1%
Net Margin	15.3%+12.5pp	2.8%-12.2pp	15.0%-21.6pp	36.5%+30.8pp	5.7%+10.4pp	-4.7%-16.2pp	11.5%+66.4pp	-54.9%
Return on Equity	2.5%+2.0pp	0.4%-2.0pp	2.4%-5.3pp	7.7%+6.6pp	1.1%+1.7pp	-0.6%-2.4pp	1.8%+9.2pp	-7.4%
Return on Assets	0.9%+0.8pp	0.2%-0.7pp	0.9%-1.9pp	2.8%+2.4pp	0.4%+0.6pp	-0.2%-0.9pp	0.7%+3.3pp	-2.7%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	1.19-0.0	1.230.0	1.230.0	1.23-0.1	1.34+0.2	1.17-0.6	1.73-0.0	1.76
FCF Margin	N/A	N/A	N/A	10.0%-10.3pp	20.3%+15.5pp	4.8%-20.0pp	24.8%	N/A

Similar Companies

Broad Street BRST

$35K

Mongolia Growth Group Ltd MNGGF

$22.4M

Ambase ABCP

$13.6M

Blaqclouds Inc BCDS

$4.6M

Uc Asset Com UCASU

$2.3M

Frequently Asked Questions

What is Zoned Pptys Inc's annual revenue?

Zoned Pptys Inc (ZDPY) reported $3.1M in total revenue for fiscal year 2025. This represents a -18.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Zoned Pptys Inc's revenue growing?

Zoned Pptys Inc (ZDPY) revenue declined by 18.8% year-over-year, from $3.8M to $3.1M in fiscal year 2025.

Is Zoned Pptys Inc profitable?

No, Zoned Pptys Inc (ZDPY) reported a net income of -$2.9M in fiscal year 2025, with a net profit margin of -92.7%.

What is Zoned Pptys Inc's EBITDA?

Zoned Pptys Inc (ZDPY) had EBITDA of -$1.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is Zoned Pptys Inc's operating margin?

Zoned Pptys Inc (ZDPY) had an operating margin of -61.2% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Zoned Pptys Inc's net profit margin?

Zoned Pptys Inc (ZDPY) had a net profit margin of -92.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Zoned Pptys Inc's free cash flow?

Zoned Pptys Inc (ZDPY) generated $775K in free cash flow during fiscal year 2025. This represents a 35.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Zoned Pptys Inc's operating cash flow?

Zoned Pptys Inc (ZDPY) generated $781K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Zoned Pptys Inc's capital expenditures?

Zoned Pptys Inc (ZDPY) invested $6K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How many shares does Zoned Pptys Inc have outstanding?

Zoned Pptys Inc (ZDPY) had 13M shares outstanding as of fiscal year 2025.

Are Zoned Pptys Inc's earnings high quality?

Zoned Pptys Inc (ZDPY) has an earnings quality ratio of -0.27x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Zoned Pptys Inc cover its interest payments?

Zoned Pptys Inc (ZDPY) has an interest coverage ratio of -2.8x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.